Maarten Naesens is Clinical Director of the Nephrology and Renal Transplantation unit of the University Hospitals Leuven. He is co-directing the kidney transplant program, with special focus on renal allograft histology, antibody-mediated rejection, HLA sensitization, living donation and ABO-incompatible transplantation. He directs the protocol biopsy program of the University Hospitals Leuven and the “Biobank Renal Transplantation” at this same institution. He is appointed Full Professor in the Department of Microbiology and Immunology at the University of Leuven. In his translational research performed at this institution, he integrates clinical, histological, and genetic and gene expression data, to get an integrated view on the determinants of inflammation and histological damage progression of renal allografts and late graft loss. Prof. Dr. Maarten Naesens was principal investigator of the FP7 project “Biomargin” of the European Commission, focusing on biomarker research for kidney transplantation by using omics strategies and systems medicine, and of the FWO TEMPLATE project for epitope matching in kidney transplantation. He has published more than 120 peer-reviewed manuscripts in international journals, amongst others in New Engl J Med, J Exp Med, Sci Transl Med, Nature Comm, J Am Soc Nephrol, Transplantation, Am J Transplant and Kidney Int. He has established collaborative projects and networks with multiple European and American research centers. He has received investigator awards from the European Society of Organ Transplantation, from the American Transplant Society and from The Transplantation Society.